Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Condition: Metastatic Colorectal Cancer
NCT03645876
SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
The study was terminated early due to company decision